Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Lantus and Lyxumia combination on insulin secretion in T2DM
NCT01910194Phase 2Completed
- Sponsor
- Profil
- Start
- Dec 2013
- Primary completion
- Oct 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of insulin glargine, lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Profil. Started Dec 2013; status: completed.
02
Drugs
insulin glarginelixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01910194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01910194.